CN1242044A

CN1242044A - Stable expression of triple helical proteins

Info

Publication number: CN1242044A
Application number: CN 97181012
Authority: CN
Inventors: P·R·沃恩; M·加拉尼斯; J·A·M·拉姆肖; J·A·维尔克梅斯特
Original assignee: Commonwealth Scientific and Industrial Research Organization CSIRO
Current assignee: Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date: 1996-10-29
Filing date: 1997-10-29
Publication date: 2000-01-19
Anticipated expiration: 2017-10-29
Also published as: AUPO331096A0; CN100335631C

Abstract

The present invention relates to a method for producing hydroxylated triple helical proteins in yeast host cells, which includes the following steps: introducing a first nucleotide sequence encoding P4Halpha subunit, a second nucleotide sequence encoding P4HBeta subunit and one or more product encoding nucleotide sequence into a suitable yeast host cell, the product encoding nucleotide sequence encodes one or more kinds of polypeptides or peptides, these polypeptides or peptides will generate the hydroxylated triple helical proteins after being hydroxylated, each of the first, second and product encoding nucleotide sequences can be operably linked to a promoter subsequence; culturing the yeast host cell under the condition that the first, second and product encoding nucleotide sequences can be expressed, thereby generating the hydroxylated triple helical proteins. The method is characterized in that the step of introducing the first, second and product encoding nucleotide sequences will cause that the first, second and product encoding nucleotide sequences and corresponding operably linked promoter subsequence will be carried on one or more replicable DNA molecules; the molecules are kept and separated stably by the yeast host cells in the culturing step. The conversion yeast host cells and triple helical proteins produced by the method of the present invention are also disclosed.

Description

The stably express of triple helical proteins

Invention field:

The present invention relates to the production of the hydroxylation triple helical proteins that undertaken by recombinant DNA technology, described albumen such as natural and synthetic collagen, natural and synthetic collagen fragment, natural and synthetical glue former state albumen.Specifically, the present invention relates to that a kind of dna sequence dna by will encode triple helical proteins and prolyl 4-hydroxylase (P4H) imports in the suitable yeast host cell and the method for in yeast host cell, producing the hydroxylation triple helical proteins, wherein, the method for importing is the dna sequence dna that is imported is stably kept by this yeast host cell and to separate.

Background of invention:

Proteic collagen family is the albumen of Mammals in-vivo content maximum, and it has constituted most of fibre composition, for example, and skin, bone, tendon, cartilage and blood vessel.Each collagen protein is by with (Gly-X-Y) _nTumor-necrosis factor glycoproteins is that the three peptide species chains (α chain) of feature are formed, and described polypeptide chain is folded into the triple helical proteins conformation.Type i collagen (being common in skin, tendon, bone and cornea) [is α 1 (I) by being called as α 1 (I) and α 2 (II) ₂α 2 (II)] two peptide species chains form, and such as II type [α 1 (II) ₃] and III type [α 1 (III) ₃] the collagen of other type have three identical polypeptide chains.These collagen proteins can spontaneously be gathered into protofibril, and this protofibril is incorporated in the extracellular matrix, and in mature tissue, it plays structure function, and in the tissue of growing, it plays directive action.Described collagen fibril is highly insoluble after crosslinked, and has very high tensile strength.

The soluble fibriilar ability of the generation of collagen makes it be hopeful to be used for multiple medical purpose, comprises that the production of biological implantation body, soft tissue increase and wound/burn bandage.Up to now, having confirmed that most of collagen of its purposes comes from Animal resources, mainly is ox.Although the described collagen that comes from animal is successfully utilized,, still have some problem: the use of this collagen can produce serious immunogenicity problem, and can disseminate infection and spongy encephalitis (for example, bovine spongiform encephalitis (BSE)).Therefore, people have great interest to the method for development and use recombinant DNA technology production collagen or collagen fragment.And, the utilization of recombinant DNA technology also has such advantage: it has brought the potential possibility of producing synthetic collagen and collagen fragment, for example, external source biologically active domain (that is: provide extra protein function) and other useful property (for example, the biocompatibility of improvement and stability) can be provided this synthetic collagen.

Biosynthesizing is the process of a complexity in the body of collagen protein, relates to a lot of translations back process.A critical process is will be positioned at multiple (Gly-X-Y) by prolyl 4-hydroxylase (P4H) _nThe locational prolyl hydroxylation of the Y-of sequence becomes 4-Hydroxyproline.Confirmed already that this hydroxylation helped the folding nucleogenesis of triple helical proteins.With regard to collagen, the stability under the body temperature is very important.Therefore, exploitation has the method for the production recombinant collagen of commercial value to need coexpression P4H and described α chain.For mammalian host cell, the coexpression of P4H can spontaneously carry out, because this class cell can be expressed P4H naturally.But,, consider, more be hopeful to be used for the express recombinant eukaryotic protein, also need to transform with the dna sequence dna of coding P4H for cost, convenience and efficient for yeast host cell.Because P4H is made up of α subunit and the β subunit of about 60kDa and 60kDa, the yeast host cell that is used for express recombinant collagen need transform with at least 3 exogenous DNA arrays (that is: coding for alpha chain, P4H α subunit and P4H β subunit), and, if be cloned in 3 independently on the carrier or all be cloned on the episomal vector then stability problem can appear in expection.In fact, even under Continuous Selection pressure, a lot of episomal vectors all can run into stability problem, if this carrier exists greatly or with lower copy number.Therefore, an object of the present invention is to provide a kind of method by yeast host cell express recombinant collagen and other triple helical proteins, wherein, the dna sequence dna that is imported does not rely on the successive selective pressure and stably keeps and separate.

Summary of the invention:

Therefore, first aspect the invention provides a kind of method of producing the hydroxylation triple helical proteins in yeast, and this method may further comprise the steps:

First nucleotide sequence of coding P4H α subunit, second nucleotide sequence and one or several product coding nucleotide sequence of coding P4H β subunit are imported a kind of suitable yeast host cell, described product coding nucleotide sequence encode one or more polypeptide or peptide, these polypeptide or peptide generate later on described hydroxylation triple helical proteins at hydroxylation, and each of described first, second and product coding nucleotide sequence all operationally is connected with promoter sequence; With

Under the condition that is suitable for expressing described first, second and product coding nucleotide sequence, cultivate described yeast host cell, thereby produce described hydroxylation triple helical proteins;

Wherein, the method is characterized in that the step that imports described first, second and product coding nucleotide sequence can cause described first, second and product coding nucleotide sequence and the promoter sequence that is operably connected accordingly is carried on one or several reproducible dna molecular, this molecule is stably kept by described yeast host cell in described culturing step and separates.

Second aspect, the invention provides a kind of yeast host cell that can produce the hydroxylation triple helical proteins, described yeast host cell comprises first nucleotide sequence of a coding P4H α subunit, second nucleotide sequence and one or several product coding nucleotide sequence of a coding P4H β subunit, described product coding nucleotide sequence encode one or more polypeptide or peptide, these polypeptide or peptide generate described hydroxylation triple helical proteins later at hydroxylation, described first, second all operationally is connected with promoter sequence with each of product coding nucleotide sequence, wherein said first, second and product coding nucleotide sequence and the promoter sequence that is operably connected accordingly thereof be carried on one or several reproducible dna molecular, this molecule is stably kept by described yeast host cell in described culturing step and separates.

The third aspect the invention provides a kind of triple helical proteins of producing according to the method for first aspect present invention.

Fourth aspect the invention provides a kind of biomaterial or treatment product that contains the triple helical proteins of producing according to the method for first aspect present invention.

Detailed Description Of The Invention:

Method of the present invention needs as follows first nucleotide sequence of described coding P4H α subunit and β subunit and second nucleotide sequence and described product coding nucleotide sequence are imported a kind of suitable yeast host cell: described sequence is carried by one or several dna molecular, and these molecules are stably kept by described yeast host cell in the training period and separate.Like this, all daughter cells all contain described first, second and product coding nucleotide sequence, and it is hereby ensured and need not use the successive selective pressure to stablize in whole culturing process and express a kind of hydroxylation triple helical proteins product effectively.

The inventive method can realize like this: (i) one or several extraneous nucleotide sequence (be in described first, second and the product coding nucleotide sequence one or several) (is for example integrated, pass through homologous recombination) in one or several karyomit(e) of yeast host cell, or (ii) in the described extraneous nucleotide sequence one or several is contained in one or several carrier that contains a kinetochore (CEN) sequence.In addition, can adopt the array configuration of above-mentioned technology, perhaps with in the above-mentioned technology one or both use and the use of one or both high copy number plasmids combine, described plasmid comprises the retainer (remainder) of described extraneous nucleotide sequence.For example, first nucleotide sequence and second nucleotide sequence of described coding P4H α subunit and β subunit can be incorporated in the host chromosome, and make described product encoding sequence be contained on one or several carrier that contains a CEN sequence or on the high copy number carrier.

Preferably, the inventive method is to realize by described extraneous nucleotide sequence is contained in one or several carrier that contains a CEN sequence.Particularly preferably be YAC (yeast artificial chromosome) carrier (Cohen etc., 1993) that contains the CEN sequence and pYEUra3 carrier (Clontech, Cat.No6195-1).Can contain the carrier of CEN sequence by a CEN sequence clone is generated other on any suitable expression vector.

When being contained in one or several extraneous nucleotide sequence on the high copy number carrier, preferably this high copy number carrier is selected from those carriers that occurs with the individual copy of each host cell 20-500 (preferred 400-500).Particularly preferred high copy number carrier is the YEp carrier.

Method of the present invention can be produced the hydroxylation triple helical proteins." triple helical proteins " speech is understood to mean homology or the heterotrimer albumen of being made up of one or more polypeptide or peptide, and described albumen comprises that at least one has the fragment of following peptide general formula: (Gly-X-Y) _nWherein, Gly is a glycine, X and Y represent identical or different amino acid (X and Y can be different between Gly-X-Y triplet and the Gly-X-Y triplet), but, wherein X and Y are generally proline(Pro), and Y wherein becomes oxyproline (Hyp) after modifying, n is 2-1500 (preferred 10-350), and this fragment forms the triple helical proteins conformation with the same or similar fragment of two other polypeptide or peptide.Therefore, this term (for example comprises natural and synthetic collagen, natural and synthetic collagen fragment and natural and synthetical glue former state albumen, macrophage scavenger receptor and pulmonary surfactant protein), and comprise equally and be with or without propetide, spherical territory and/or interleave non-collagen sequence and be with or without all precollagens and the collagen (for example, I-XIX type) that comes from the natural of people or other species or variant aminoacid sequence.Synthetic collagen that " triple helical proteins " speech is included and fragment can also comprise the non-collagen that is positioned at its amino and/or C-terminal or other position, non-triple helix territory.

Therefore, the product coding nucleotide sequence that is applicable to the inventive method can be diversified.But, described product coding nucleotide sequence is preferably selected from coding natural collagen and segmental nucleotide sequence thereof, as COL1A1 (D ' Alessio etc., 1988; Westerhausen etc., 1991), COL1A2 (de Wet etc., 1987), COL2A1 (Cheah etc., 1985) and COL3A1 (Ala-Kokko etc., 1989) and fragment thereof and combination and synthetic collagen and fragment thereof.

Fragment or its various combinations that coding natural collagen or its segmental product coding nucleotide sequence can be encoded and be comprised or got rid of N-propetide district, N-end peptide, C-end peptide or C-propetide.

Synthetic collagen of coding and segmental product coding nucleotide sequence optimized encoding thereof have the polypeptide or the peptide of following general formula: (A) _l-(B) _m(Gly-X-Y) _n-(C) _o-(D) _pWherein, Gly is a glycine, X and Y represent identical or different amino acid, X and Y can be different between Gly-X-Y triplet and the Gly-X-Y triplet, and but, Y wherein is necessary 〉=1 proline(Pro), A and D are polypeptide or peptide domain, and it can comprise or not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, B and C are intervening sequences, it does not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, n are 2-1500 (being preferably 10-300), and l, m, o and p are selected from 0 or 1 independently of one another.

Described product coding nucleotide sequence can comprise the sequence of a coding secretion signal, so that secretion is by described product coding nucleotide sequence polypeptide expressed or peptide.

The expression of product coding nucleotide sequence can be by composing type Yeast promoter sequence (for example, ADH1 (Hitzeman etc., 1981, Pihlajaniemi etc., 1987), HIS3 (Mahadevan﹠amp; Struhl, 1990) startup, 786 (anonymity, 1996 innovations 5,15) and PGK1 (Tuit etc., 1982)), but, more preferably by such as GAL1-10 (Goff etc., 1984), GAL7 (St.John﹠amp; Davis, 1981), the induction type Yeast promoter sequence of ADH2 (Thukral etc., 1991) and CUP1 (Macreadie etc., 1989).

First nucleotide sequence and second nucleotide sequence of described coding P4H α subunit and β subunit can come from all animals, and but, it preferably comes from bird or Mammals, particularly people (Helaakoski etc., 1989).It is also contemplated that described first nucleotide sequence can come from different species with second nucleotide sequence.In addition, second nucleotide sequence of coding P4H β subunit (for example can comprise coding endoplasmic reticulum (ER) stick signal, HDEL, KDEL, KEEL) sequence, this sequence is with or without other targeting signal, so that described P4H can express in ER, tenuigenin or target cell device, perhaps can be secreted.

The expression of described first and second nucleotide sequences can be started by above-mentioned composing type or induction type Yeast promoter sequence.But, it is believed that, realize that with coordinated mode the expression of described α subunit and β subunit is favourable, but preferably use the two-way startup subsequence with identical or different promoter sequence with identical inducing properties.Correspondingly, preferably reach described first and second nucleotide sequences with GAL1-10 yeast two-way startup subsequence table, but, other two-way startup subsequence is suitable equally.

First, second and/or product coding nucleotide sequence of multiple copied can be imported yeast host cell (for example, be present on the yac vector or be incorporated in the host chromosome).It may be particularly advantageous providing described product coding nucleotide sequence with a plurality of copies, therefore, preferably described product coding nucleotide sequence is imported high copy number plasmid (for example, YEp plasmid).

Imported first, second and product coding nucleotide sequence can be carried at one or several stable keep and isolated DNA molecule on.When being carried by more than one dna molecular, described dna molecular can be the combination of the combination of host chromosome and/or carrier that contains the CEN sequence and high copy number carrier.Transform some special case of the yeast host cell that is applicable to the inventive method with following dna molecular: 1.YEp-P3+pYEUra3-α β, 2.YEp-P3+pYAC α β 3.YEpCEN-P3+pYEUra3-α β 4.YEpCEN-P3+pYAC α β 5.pYAC-P3+pYAC α β 6.pYAC-P3+pYEUra3-α β 7.pYAC α β-P3;

Wherein, P3 represents the product coding nucleotide sequence, and α and β be the nucleotide sequence of presentation code described P4H α subunit and β subunit respectively, and CEN represents the centromeric sequence that imports.Described pYEUra3 and pYAC carrier comprise the CEN sequence.

Can be from the triple helical proteins product (Miller﹠amp that produces with the inventive method by purifying the yeast host cell of cultivating by the technology that comprises standard chromatography and precipitation technology; Rhodes, 1982).Concerning collagen, can use pepsin and NaCl precipitation technology (Miller﹠amp; Rhodes).Immunoaffinity chromatography can be used for the structure that purifying contains suitable recognition sequence, described sequence if can be by the Flag sequence of M1 or M2 monoclonal antibody identification, or the triple helix epi-position, the epi-position (Glattauer etc., 1997) that if can be discerned by antibody 2G8/B1.

The yeast host cell that is applicable to the inventive method can be selected from some genus, and these genus include but not limited to yeast belong, genus kluyveromyces, Schizosaccharomyces, Yarrowia and Pichia.The optional home-brewed wine yeast of particularly preferred yeast host cell (S.cerevisiae), Kluyveromyces lactis (K.lactis), schizosaccharomyces pombe (S.Pombe), Y.Lipolytica and pichia pastoris phaff (P.pastoris).

As indicated above, particularly preferably be by transforming described first, second imported yeast host cell with the product coding nucleotide sequence with one or several yac vector, yac vector is linear dna vector, it comprises yeast CEN sequence, at least one (for example comes from zymic self-replicating signal usually, and telomere end (also being to come from yeast usually) ars).They also comprise a yeast selective marker such as URA3, TRP1, LEU2 or HIS3 usually; and; (for example, sup4-o) this gene can carry out the red/white color selection in needing the bacterial strain of VITAMIN B4 (that is: the VITAMIN B4 transgenation that produces owing to the ochre terminator codon in advance) also comprising ochre suppressor under some occasion.More commonly comprise two yeast selective markers, one (being separated by CEN between each arm) respectively arranged on each arm of artificial chromosome.Can only choose the conversion host of containing following YACs like this, on desirable restriction cloning site, have interested importing sequence.In other words, correctly insert two arms that interested sequence (for example, expression cassette) can reconnect confined YAC, therefore make transformant become the prototroph of two kinds of marks.YACs is designed to big extraneous nucleotide sequence (being the 100kb or the bigger order of magnitude) importing yeast host cell.The inventor will confirm below that described YACs can be used for the stably express of a plurality of extraneous nucleotide sequences (for example, the nucleotide sequence of coding natural collagen and P4H α subunit and β subunit).

In certain embodiments of the invention, preferably by transform with one or two YEp carrier will be described first, second with the product coding nucleotide sequence in one or several (but not being whole) import described yeast host cell.The YEp carrier has all or part of of yeast 2 μ plasmids, but has replication orgin (ori) at least.Described carrier also comprises the yeast selective marker such as HIS3, LEU2, TRP1, URA3, CUP1 or G418 resistance; and; usually also contain an independently ori who is used in intestinal bacteria (E.coli) operations, be generally ColE1 and such as the mark of the blue or green plain resistance of ammonia benzyl.Described carrier has high copy number, and for example each cell has 20-400 copy, and, can effectively separate usually.Stability during cell fission depends on the plasmid that contains the REP2/STB site that comes from described 2 μ plasmids equally.But, host's endogenous 2 μ plasmids are not good as described for stability, particularly when inducing heterogenous genetic expression.Stability also can be along with the increase of plasmid size descend (Wiseman, 1991).

In this manual, " comprising " (comprise, comprises and comprising) speech is intended to contain specific composition or feature or composition or feature group, comprises or do not comprise other composition or feature or composition or feature group.

To the present invention be described by mode below in conjunction with following non-limiting examples and accompanying drawing.

Brief description of drawings:

The structure (being labeled as pYEUra3-M β α) of Fig. 1 graphic representation expression vector pYEUra3.2.12 β #39 α #5.

Fig. 2 represents the nucleotide sequence of COLIII 1.6kb DNA.

People's collagen I II gene fragment that Fig. 3 graphic representation is separated to by PCR.Also show the 1.6kb DNA that is used for following examples.Should be appreciated that other fragment shown in the available figure replaces the COLIII 1.6kb DNA among these embodiment.

The structure of Fig. 4 graphic representation expression vector YEpFlagCOLIII 1.6kb (being labeled as YEpFlagC-3).

The structure of Fig. 5 graphic representation pYAC5 β α.

The structure of Fig. 6 graphic representation pYAC5 β α-COLIII 1.6kb.

Fig. 7 represents the structure of synthetic collagen goods.

Fig. 8 provides the nucleotide sequence of SYN-C3 and the aminoacid sequence of encoded polypeptides thereof.

Embodiment:

Example 1: structure is used for the collaborative coexpression prolyl-α of 4-hydroxylase and yeast vector of β subunit.

The production of Yeast expression carrier:

PYEUra3 (Clontech) contains the bidirectional promoter that is useful on the GAL1-10 expression.Do not having under the condition of glucose, by inducing with semi-lactosi, pGAL1 can high level expression by all albumen that insert the dna encoding of MCS (multiple clone site) [XhoI, SalI, XbaI or BamHI site] with correct orientation, as long as an ATG initiator codon is arranged.Concerning pGAL10, if dna sequence dna to be expressed is the form insertion with the ATG codon frame that meets GAL10, and dna sequence dna to be expressed is to insert the EcoRI site, then can take place to be expressed by the semi-lactosi inductive.

For the EcoRI site being used for the clone, make and insert the formal representation that fragment needn't meet the ATG frame of GAL10, must modify pYEUra3, to remove the initiator codon of GAL10.Described purpose is to realize like this.Make template with pYEUra3, and use primer 3465[5 ' CTG.TAG.Agg.atc.cCCGGG.TAC.GGA.GC-3 ', wherein, by the represented BamHI site of nucleotide coding of lowercase] and primer 1440[5 ' TTA.TAT.Tga.att.cTC.AAA.AAT.TC3 ', wherein, by the represented EcoRI restriction site of nucleotide coding of lowercase] preparation PCR fragment.Primer 1440 imports pYEUra3 with an EcoRI site, is located at the initial ATG front of GAL10.Limit this PCR fragment with BamHI and EcoRI, and it is cloned on the same pYEUra3 that digested with BamHI and EcoRI, replace BamHI and the EcoRI fragment that contains the ATG initiator codon with BamHI that lacks ATG and EcoRI fragment, to generate plasmid pYEUra3.2.12.Then can be with this EcoRI site as cloning site, for this reason, must provide an initiator codon by the dna sequence dna that inserts by making MCS be positioned at the other end of promotor, thereby be placed under the bidirectional promoter pGAL1-10 control, and its expression can be induced by semi-lactosi because of the MCS site that dna sequence dna inserts this promotor the other end.Dna sequence dna is cloned into MCS and coordinate expression can be carried out by described bidirectional promoter in the EcoRI site when inducing with semi-lactosi.

Extract the α subunit of the described P4H of coding and the dna molecular of β subunit:

Use primer 1826[5 '-TGT.AAA.ATT.AAA.gga.tcc.CAA.AG.ATG.TGG.TAT-3 ', lowercase coding BamHI site, ATG is the initiator codon of α subunit] and primer 1452[5 '-GCCG.gga.tcc.TG.TCA.TTC.CAA.TGA.CAA.CGT-3 ', lowercase coding BamHI site, TCA translation stop codon] by cDNA (Clontech Human KidneyQuik Clone ^TMCDNA Cat.#7112-1) the α subunit of pcr amplification P4H.Obtained two kinds of isotypes, and it be cloned into storage carrier pBluescriptII SK+[StratageneCat.#212205] the BamHI site, to obtain pSK+ α 1 (I type) and pSK+ α 2 (II type).No BamHI site on the DNA of the described α subunit of coding.Be used for the BamHI fragment that the excretory signal sequence is present in two kinds of forms.

With primer to 2280[5 '-AC.TGG.ACG.GAT.CCC.GAG.CGC.CCC.GCC.TGC.TCC.GTG.TCC.GAC.A TG-3 '] and 2261[5 '-G.GTT.CTC.CTT.ggt.gac.cTC.CCC.TT-3 ', wherein, the nucleotide coding BstEII site of representing by lowercase] be used for the N-terminal part of β subunit, with primer to 2260[5 '-GAA.GGG.GAg.gtc.acc.AAG.GAG.AAC-3 ', wherein, the nucleotide coding BstEII site of representing by lowercase] and 1932[5 ' CC.TTC.AGG.ATC.CTA.TTA.GAC.TTC.ATC.TTT.CAAC.AGC-3 '] be used for the C-terminal part of β subunit by cDNA (Clontech Human Kidney Quik Clone ^TMCDNACat.#7112-1) the β subunit of pcr amplification P4H [the PDI/ protein disulphideisomerase is otherwise known as] [Pihlajaniemi etc., 1987].With above two PCR fragments of BstEII digestion β subunit, and then link together, to generate the single fragment of the complete β subunit of coding.Use primer 2 280[5 '-AC.TGG.Acg.gat.ccC.GAG.CGC.CCC.GCC.TGC.TCC.GTC.TCC.GAC.A TG-3 ' then, wherein, ggatcc coding BamHI site, ATG is the initiator codon of β subunit] and primer 1932[5 '-CC.TTC.Agg.atc.cTA.TTA.GAC.TTC.ATC.TTT.CAC.AGC-3 ', wherein, ggatcc coding BamHI site, TTA is translation stop codon of β subunit] this fragment increases, be cloned into the BamHI site of pBluescript SKII+ again, to obtain preserving carrier pSK+ β.Subsequently, use primer 2 698[5 '-CTA.GTT.gaa.ttc.TAC.ACA.ATG.CTG.CGC.CGC.GCT.CTG.CTG-3 ', wherein, gaattc coding EcoRI site, and ATG is the initiator codon of β subunit] and 2699[5 '-GCA.ATG.gaa.ttc.TTA.TTA.CAG.TTC.GTG.CAC.AGC.TTT-3 ', gaattc coding EcoRI site, provide two translation stop codon by TTA.TTA., and change Methionin [K] residue into Histidine [H] residue by GTG, so that a unartificial yeast ER stick signal HDEL (being His.Asp.Glu.Leu) to be provided, rather than Mammals KDAEL ER stick signal] the BamHI fragment of amplification pSK+ β.Then resulting PCR fragment flush end is cloned into pCRScript[Stratagene, Cat.#211190] the SrfI site, to generate pCRScript β.From pCRScript β, reclaim the EcoRI fragment that contains the β subunit by EcoRI digestion, and then with the EcoRI site of this fragment cloning to pCRScript, to generate pCRScript β EcoRI#4.

Structure comprises the α subunit of the P4H that encodes and the segmental Yeast expression carrier of β subunit:

From the EcoRI digestion product of pCRScript β EcoRI#4, obtain the fragment of described β subunit with the EcoRI pieces.With the EcoRI site of this EcoRI fragment cloning, to generate plasmid pYEUra3.2.12 β #39 to pYEUra3.2.12.The α subunit fragments that will come from pSK+ α 1 with BamHI is excised from pSK α 1 again, and is cloned into the BamHI site of pYEUra3.2.12 β #39, to generate pYEUra3.2.12 β #39 α #5 (Fig. 1).Described β subunit fragments is controlled by pGAL10, and the α subunit fragments is controlled by pGAL1.This is a kind of bidirectional promoter, and it makes two subunits of prolyl-4-hydroxylase can carry out inductive coordination expression.Two kinds of fragments all provide a natural A TG translation initiation codon.Coded β subunit has the secretion signal of self and is positioned at HDEL endoplasmic reticulum reservation (ER) sequence of described proteic C-terminal.Although coded α subunit with himself signal sequence does not have the ER stick signal, but it can be kept by the interaction with the β subunit.

Example 2: collaborative coexpression and III type hydroxylation collagen synthetic of collagen fragment and prolyl-4-hydroxylase (α and β subunit) in yeast.

Prepare the recombinant collagen fragment of 1.6kbp, employed primer 1989[forward primer 5 '-gct.agc.aag.ctt.GGA.GCT.CCA.GGC.CCA.CTT.GGG.ATT.GCT.GGG-3 ' by PCR] and 1903[reverse primer 5 '-tcg.cga.tct.aga.TTA.TAA.AAA.GCA.AAC.AGG.GCC.AAC.GTC.CAC. ACC-3 '] with a part of homology of III Collagen Type VI α I chain (COL3A1).Being used to extract the segmental template of III Collagen Type VI α 1 chain is to use the Witzard purify DNA available from cDNA library [HL1123n λ Maxl Clontech Lot#1245, people's kidney cDNA 5 '-fragment library] to prepare.

The segmental actual size of the isolating 1.6kbp of institute is 1635bp, comprises the COL3A1DNA of 1611bp, and a 12bp fragment that comes from described primer is respectively arranged in its both sides.The COL3A1 DNA of 1611bp is equivalent to the Nucleotide #2713-4826 (that is: codon #905-1442) of complete encoding sequence, therefore, has comprised the segmental part of alpha-helix, and C-holds the whole of peptide, the whole and terminator codon of C-propetide ^{* 1}The nucleotide sequence of COL3A1 DNA is provided in Fig. 2.Figure 3 illustrates the fragment that covers by COL3A1 DNA.At NheI[GCTAGC of described 1.6kbp segmental 5 ' terminal interpolation] site and a HindIII[AAGCTT] site, at XbaI[TCTAGA of its 3 ' terminal interpolation] site and NruI[TCGCGA] site is [wherein, its 5 ' end is the forward along this frame, promptly the derive N-terminal of encoding sequence, and 3 ' end comes from described reverse primer, is equivalent to the 3 ' end of this gene and the C-terminal of institute's derived amino acid sequence].Give described collagen fragment portability thus.

With described 1.6kbp fragment cloning to YEpFlag1[IBI products catalogue #13400] the SmaI site on, make its encoding sequence incorporate the proteic frame of vector expression Flag.The glue protogene fragment that is imported when making like this on growing in ethanol can the fusion rotein form meet the expression of frame ground.Flush end the clone be performed such: under 20 ℃, carrier sequence [gel-purified] and the 1.6kbp PCR fragment [gel-purified that connects SmaI digestion under the condition of SmaI arranged, non-phosphorylating], with recirculation that prevents carrier self and the level that reduces the false positive transformant.On the collagen dna fragmentation that is used to clone, there is not SmaI, NheI, HindIII, XbaI or NruI site.

Come from the small-scale prepared product [using method with Bio101 post and this post of being introduced prepares] in a small amount of the DNA of intestinal bacteria amicillin resistance bacterium colony by restriction enzyme analysis screening.In order to prepare, need 10ml culture rather than 1ml culture, in intestinal bacteria because the YEpFlag plasmid is not to occur with high copy number for an amount of DNA that analyzes usefulness.

Described fusion rotein is following form: be used to be directed to ER and the yeast alpha factor signal sequence of the yeast secretary approach of finalizing the design, yeast alpha factor propetide with kex 2-endopeptidase cracking site, cause all alpha factor amino-acid residues cut, and generate a N-terminal by free F lag mark, be used for detecting and mark fusion rotein (8 amino-acid residues), connection peptides (4 amino-acid residues), collagen helix (255 amino-acid residues), the Flag peptide (helping the formation of triple helix) of collagen C-end peptide [C-tel] (25 amino-acid residues) and C-propetide [C-pro] (255 amino-acid residues).The Flag-labelled protein of expectation is made up of 547 amino-acid residues, and desired molecular weight MW is about 60kDa.

The expression of described fusion rotein in YEpFlag1 is subjected to the control of ADH2 promotor, and this promotor is suppressed by glucose, but under the condition that ethanol (byproduct of glucose metabolism) arranged activity arranged.Owing in described carrier, there is the replication orgin of yeast 2 μ plasmids, the a plurality of copies that in one yeast conversion body, have this carrier, like this, after growing period has been removed the glucose inhibition owing to consumption, can cause described 1.6kbp PCR collagen fragment high level expression.The characteristic feature of this clone's scheme is described 1.6kbp PCR collagen fragment to be inserted the back with misorientation just can not generate fusion product, because the leucine residue of terminator codon front is encoded by AAT.Oppositely insertion only increased leucine coding password [terminator codon TAA is exactly AAT conversely] with regard to the result who has produced a terminator codon TAA mistake insertion after the Flag sequence before this albumen stops.

The aminoacid sequence of described Flag-mark fusion rotein on merging point is N-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-[Flag]-the Ala-Ser-Lys-Leu-[joint]-the Gly-Ala-Pro-Gly-Pro-Leu-Gly-Ile-Ala-[alpha-helix].

By with electric shock lithium acetate transforms or spheroplast regeneration with described YEpFlag collagen structure [below be referred to as YEpFlagCOLIII 1.6kb; Fig. 4] importing tryptophane prototroph yeast strain, for example, BJ3503[pep4 ∷ HIS3 prb-1.6R HIS3 lys2-208 trp1-101 ura3-52gal2 can1], BJ5462[α ura3-52 trp1 leu2-1 his3-200 pep4 ∷ HIS3prb-1.6R can1 GAL], (YGSG) HRY1-5D α [α his4-519 ura3-52leu2-3 leu2-112 trp1 pep4-3] or KRYD1[BJ3505xBJ5462 diploid].Obtain tryptophane auxotroph transformant, change YPHSM over to according to the scheme that provides in the YEpFlag expression system [IBI products catalogue #13400], YEPM or YEPD or YEPGal, YEPE grows to high-cell density then in selective medium [shortage tryptophane].Prepare 1ml culture aliquots containig when after inoculation, growing to 3-9 days, and by on desk centrifuge with speed centrifugation precipitation and the supernatant liquor of 13000rpm.All yeast sedimentation are suspended in again contain PMSF[0.002M] 100 μ l gel loading buffers [5XSDS] in, violent vortex 2 minutes, and boiling 5 minutes.From described precipitation, keep 900 μ l supernatant liquors, to wherein adding 100 μ l 5XSDS/0.002M PMSF, and handle to handle precipitation mode.By Western engram analysis analysis precipitation and supernatant liquor 20 μ l aliquots containigs, this analysis is being transferred to yeast SDS-PAGE total protein or supernatant liquor (substratum) on the nitrocellulose and this filter membrane is being carried out finishing after the prehybridization in blotter.The Western engram analysis is with the α-anti-N-free end of Flag Mab M1[Flag] and (international biotech company (Eastman Kodak) catalog number: IB13001) or the anti-Flag of M2[] (international biotech company (Eastman Kodak) catalog number: IB13010) carry out.

The Western trace has confirmed the existence of the protein band of an about 60kDa.This is the expectation size that contains the albumen syzygy of Flag-spiral-C-tel-C-pro.After the delay incubation, Flag effect antibody can detect the existence of fusion product in substratum.With M1 antibody precipitation and medium supernatant being detected confirmation alpha factor leader sequence has been excised fully.Do not observe precursor forms with the preceding fragment (glycosylation or not glycosylation) of alpha factor.

Available from the albumen of unconverted yeast host do not obtain can with the band that is equivalent to 60kDa of M1 or M2 hybridization.When using the yeast of only using YEpFlag (do not have and insert fragment) conversion, in precipitation, obtained hybrid belt, but just obtain with M2 Mab.These bands are equivalent to α-preceding fragment and the various glycosylation form thereof that excretory not has the terminal Flag of C-.In supernatant liquor, do not detect Flag, but that is to be expected, because it only has 8 amino acid longs.Having under the condition of glucose, do not observing the expression of any structure that starts by the ADH2 promotor.

Also YEpFlagCOLIII 1.6kb can be imported altogether the yeast strain of (cotransformation) such as BJ5462 and KRDY1, this bacterial strain can with pYEUra3[Clontech] [pYEUra3 and derivative thereof contain two-way GAL1-10 promotor.ADH2 and GAL1-10 promotor all are subjected to the inhibition of glucose.The GAL1-10 promotor is induced by semi-lactosi] or a kind of improved form of the described Clontech parental generation of pYEUra3.2.12[carrier, it can be with gene clone to the EcoRI site, and the gene that is imported is in the correct frame] or pYEUra3.2.12 β #39[is wherein, the DNA of coding β subunit (protein disulphideisomerase that is equivalent to prolyl-4-hydroxylase) is cloned into the EcoRI site of pYEUra3.2.12, place under the control of GAL10 promotor] or pYEUra3.2.12 β #39 α #5[is wherein, the DNA of the α subunit of coding P4H is cloned into the BamHI site of pYEUra3.2.12 β #39, places under the control of GAL10 promotor] be grown on the semi-lactosi together.

Select transformant lacking tryptophane or uridylic or lack simultaneously on the substratum of tryptophane and uridylic.The method that transforms body with the tryptophane that carries YEpFlag or YEpFlagCOLIII 1.6kb that is obtained above the processing is the same, allow transformant grow in earlier and select in the substratum, regeneration is longer than among YPHSM, YEPM, YEPD, YEPG or the YEPE, and after 4 days, add semi-lactosi, making its final concentration is 2%, 0.5% or 0.2%.By Western engram analysis analyzing total Yeast protein or supernatant liquor, different is also to have used the 5B5 of the anti-β subunit of the third MAb[as stated above] (Dako company, catalog number M877).

The same with the situation of above handling the transformant that obtains by the conversion of simple substance grain, with MAb M1 or M2 screening the time, the Western engram analysis has confirmed to exist the band of about 60kDa in trp-that is transformed by YEpFlagCOLIII 1.6kb or trp-ura-yeast, and the YepFlag transformant should band.

Only after inducing and to have only the concentration when semi-lactosi be under the situation of 0.2-0.5% rather than 2% with semi-lactosi, with anti-β subunit MAb 5B5 screening the time, analyze the band that has also confirmed in add ura-that YepFlag or YEpFlagCOLIII 1.6kb transform or ura-trp-(but not being trp-) yeast by pYEUra3.2.12 β #39 or pYEUra3.2.12 β #39 α #5 or by it, to exist about 60kDa.The expectation size of β subunit also is 60kDa.In single uracil auxotrophy yeast that transforms with pYEUra3.2.12 β #39 or pYEUra3.2.12 β #39 α #5, detect less than this band with M1 or M2.

When experiment, be not used in detection by being present in the bidirectional promoter GAL1 on the pYEUra3.2.12 β #39 α #5, the antibody of the 10 α subunit expressions that start, but because the promotor of GAL1 and GAL10 coinduction normally, and be to be subjected to same UAS (upstream activating sequence) control in yeast, therefore, inferring also can transcript and expression at the local α subunit that confirms the β subunit expression.In order to verify this supposition, inducing with 0.2% semi-lactosi and after growing at least four days on the YPHSM, detecting the ability that pYEUra3.2.12 β #39 α #5/YEpFlagCOLIII 1.6kb cotransformation body produces functional P4H.Add semi-lactosi later at the Flag collagen expression that is unequivocally established, its expression is that the shortage by the reaction of the MAb 5B5 of the positive reaction of Yeast protein and M1 or M2 in the Western trace and anti-β subunit confirms.After inducing (16hr) with semi-lactosi, detected albumen once more, confirmed the existence of M1 or M2 effect belt and 5B5 effect belt respectively.After carrying out SDS-PAGE, albumen is transferred on the pvdf membrane, and this film is cut into inch strips.Be hydrolyzed and amino acid analysis to containing the film bar that comes from corresponding to the part of 60kDa effective-site.Amino acid analysis has confirmed after inducing with 0.2% semi-lactosi, in yeast cotransformation body material, there is oxyproline with YEpFlagCOLIII 1.6kb and pYEUra3.2.12 β #39 α #5 cotransformation, be with or without under the condition of semi-lactosi, in coming from the albumen of control sample, all do not detecting oxyproline.

Used substratum contains the peptone that comes from the bovine protein hydrolyzate, but does not all find oxyproline in the yeast of the full yeast on growing in this substratum or any single conversion (carrier is only arranged).Only in the 60kDa of yeast cotransformation body band, and only when adding semi-lactosi, just can detect oxyproline.What wherein Flag detection collagen obtained expressing does not induce transformant [no semi-lactosi] after shifting, and does not contain any oxyproline its 60kDa that excises from PVDF band.Oxyproline exists only in the 60kDa part, and is not present in the other parts of this trace.

Described conclusive evidence is induce pYEUra3.2.12 β #39 α #5 with semi-lactosi after, to have generated a kind of product in yeast, the proline residue on this product energy hydroxylation coexpression Flag-mark collagen fragment.Above-mentioned activity is not present in unconverted yeast or the yeast [no α subunit] that transforms with pYEUra3.2.12 β #39 or grow in not inducing in the yeast on ethanol or the glucose.

The above-mentioned outstanding advantage that coexpression is produced the method for hydroxylation collagen in yeast is that three genes can be coordinated to express in the cotransformation body.Another advantage is that α and β subunit itself are to coordinate to express.The 3rd advantage is that α β expression vector (being pYEUra3.2.12 β #39 α #5) contains a centromeric sequence, and its behavior such as same minichromosome.Therefore, this carrier is very stable, and does not need selective pressure to keep its stability.As if the cancellation selective pressure can not influence the stability of YEpFlag collagen structure in yeast, because it has very high number of copies, but it is evident that, if α, β and collagen fragment are cloned in respectively on the multi-copy vector, it is important that the ability of maintenance single plasmid under the condition that lacks selective pressure is only arranged, rather than the balance selective pressure is important to the influence of three kinds of independent plasmids.In addition, be better than with different promoters, on different plasmids, reach them with a synchronous express alpha of bidirectional promoter and β subunit with different scales.Described α subunit may need synthetic equivalent or relatively large β subunit, so that correctly be assembled into functional P4H (α ₂β ₂) enzyme, and, coordinate to express the actual mechanism of guaranteeing that seemingly above-mentioned purpose realizes.

* ¹[the codon numbering of III Collagen Type VI α 1 chain: ATG, No. 1 codon; No. 1 codon-No. 24 codon, signal sequence; No. 25 codon-No. 116 codons, the alpha-helix sequence; No. 117 codon-No. 130 codons, N holds peptide sequence; No. 131 codon-No. 1161 codons, the alpha-helix sequence; No. 1162 codon-No. 1186 codons, C-holds peptide; No. 1187 codon-No. 1441 codons, the C-propetide; No. 1442 codons stop] and [the corresponding Nucleotide numbering of III Collagen Type VI α 1 chain: 1-72 Nucleotide, signal sequence; 73-348 Nucleotide, the N-propeptide sequence; 349-390 Nucleotide, N-holds peptide; 391-3983 Nucleotide, the alpha-helix district; 3984-4058 Nucleotide, C-holds peptide; 4059-4623 Nucleotide, the C-propeptide sequence; 4824-4826 Nucleotide, terminator codon].

Example 3: carry out prolyl-α of 4-hydroxylase [P4H] and the coordination of β subunit expression with yeast artificial chromosome [YACs]

Digest pYAC5[11454bp with BamHI] (Kuhn and Ludwig, 1994), to discharge the HIS3 gene [1210bp] between 2 telomere ends, and with SalI-NruI digestion to produce two fragments [left arm: fragment 1,5448bp and right arm: fragment 2,4238bp], these two fragments are carried out gel-purified.Fragment 1 is BamHI-telomere end-intestinal bacteria starting point-β-Nei Xiananmei gene [amicillin resistance]-TRP1-ARS1-CEN4-tRNAsup-o-SalI.Fragment 2 is BamHI-telomere end-URA3-NruI.

With SalI-EcoRV digestion pYEUra3.2.12 β #39 α #5,, it is carried out gel-purified to generate the P4H expression cassette fragment [4864bp] of SalI-XbaI-BamHI-α-ATG-BamHI-pGAL1-10-EcoRI-ATG-β-EcoRI-SmaI-EcoRV form.With this expression cassette fragment that is subjected to the α of coding P4H of semi-lactosi induction type bidirectional promoter control and β subunit with link together with the BamHI-SalI-NruI digestion fragment 1 and 2 that pYAC5 produced, and will connect mixture and be used for transforming following yeast strain: BJ2407[a/ α prb1-11222/prb1-1122 prc1-407/prc1-407 pep4-3/pep4-3 leu2/leu2trp1/trp1 ura3-52] by the lithium acetate method for transformation, KRYD1[a/ α ura3-52/ura3-52 trp1-Δ 101/trp1lys2-208/LYS2 HIS3/his3 Δ 200 gal2/GAL2 can1/can1pep4 ∷ HIS3/pep4 ∷ HIS3 prb1 Δ 1.6R/prb1 Δ 1.6R], GY1[α leu2 ade1trp1 ura3], JHRY1-5D α [α his4-519 ura3-52 leu2-3 leu2-112 trp1pep4-3] and YPH150[α/a ura3-52/ura3-52 lys2-801a/lys2-801aade1-101o/ade1-101o leu2 Δ 1/leu2 Δ 1 trp1-Δ 63/trp1-Δ 63 his3 Δ 200/his3 Δs 200].The pYAC5 transformed yeast bacterial strain of also using the pYAC5 that digested by BamHI and not digesting.

Obtain the Ura of all bacterial strains ⁺Trp ⁺The cotransformation body, wherein, two fragments of pYAC5 are carried TRP1[SalI-CEN4-TRP1-BamHI separately] [fragment 1] or URA3[NruI-URA3-BamHI] selective marker of [fragment 2] conduct conversion on each arm of YAC, by the P4H expression cassette is inserted the SalI-EcoRV site these two fragments are linked together.This carrier is named as pYAC5 β α (Fig. 5).This carrier is following form: two sites of BamHI-telomere-URA3-NruI/EcoRV[are all destroyed]-β-ATG-pGAL10-1-ATG-α-SalI-tRNAsup-CEN4-ARS1-TRP1-AMPr-starting point-telomere-BamHI.The existence of CEN4 sequence means behavior such as the same stable karyomit(e) of this carrier between replicative phase, and mitotic division during with reduction division each cell distribute a copy [identical] at least with the situation of pYEUra3.2.12 β #39 α #5.The kinetochore end means that this carrier is linear with stable.

Transformant and contrast [only there is pYAC5 (ring-type), make linearization of pYAC5 with BamHI digestion] xerox on the nitrocellulose filter that covers selection substratum [the SD perfect medium that lacks uridylic and tryptophane] or enriched medium [YEpD], and at 30 ℃ of following incubation 2-5 days, up to being paved with.Filter membrane is transferred to the selection substratum that contains semi-lactosi [2%] rather than glucose or contain on the enriched medium and dextrose culture-medium flat board of semi-lactosi [2%], and 30 ℃ of growths 2-72 hour down.When cultivating end, the bacterium colony cracking on 0.1%SDS-0.2N NaOH-0.1% beta-mercaptoethanol, is washed with water, and seals with Blotto.By allowing the filter membrane handled and the Mab[Mab 9-47H10 single-minded to the α subunit] (ICN biologics company, catalog number 631633) and the Mab[Mab 5B5 single-minded to the β subunit] hybridization confirms the α subunit of P4H and the generation of β subunit.Also be proved and hybridize with the MAb of anti-P4H subunit with what pYAC5 β α transformed, show and to coordinate to produce α and β by two-way GAL1-10 promotor with semi-lactosi inductive bacterium colony.Contrast filter membrane and contrast yeast can not produce reaction to P4H MAbs.The yeast conversion body that has pYAC5 β α that is grown on the glucose [a kind of inhibitor of two-way GAL1-10 promotor] can not produce positive reaction yet.

Lack ura and trp and select the positive transformant in the above-mentioned screening method of evaluation in the 10ml liquid nutrient medium of substratum or the enriched medium [containing glucose, glycerine or raffinose] containing.Aliquots containig is transferred in the inducing culture [selecting or enriched medium] that contains the 0.2-2% semi-lactosi.Glucose wherein is carbon source, and washed cell precipitates in sterilized water before inducing.At 30 ℃ of following continued growth 2-20 hours, the collecting cell precipitation was suspended in the sample loading buffer then, separated full Yeast protein on SDS-PAGE, and carried out the Western trace.Seal filter membrane with blotto, and with the MAbs hybridization of two subunits of anti-P4H.Only contain pYAC5 β α's and the yeast conversion physical efficiency of inducing with semi-lactosi produce the 60kDa α and the β subbasal band of expection.This shows in the functional already pYAC5 of being inserted into of P4H expression cassette.The P4H expression cassette is inserted into has two-fold advantage in the pYAC: [1] is the same with the situation of pYEUra3.2.12 β #39 α #5, the existence of CEN sequence means that this carrier can be stablized after removing the selective pressure that grows in the enriched medium and remains in this system, this can improve output by improving cell density, can subsequently a plurality of different triple helical proteins expression cassettes inserted with [2] pYAC5 β α structure.

Example 4: collagen/triple helical proteins fragment is expressed and the P4H subunit is containing expression in the yeast conversion body of pYAC5 β α in the coordination on the multiple copied plasmid.

With YEpFlagCOLIII 1.6kb or single yeast host bacterial strain that contains pYAC5 β α or pYAC5 that transforms with YEpFlag.The carrier that contains collagen that is produced is cyclic and multiple copied.In this case, because YEpFlagCOLIII 1.6kb all contains identical selective marker with the pYAC structure, by MAbs[M1 or M2 with anti-Flag] can identify the yeast conversion body of the collagen of generation Flag mark with colony hybridization.Whether the screening bacterium colony carries the bla gene [multiple copied] of additional copy, and this screening is performed such: measure by PADAC and identify the bacterium colony (Macreadie etc. 1994) that can produce a large amount of β-Nei Xiananmeis.Can use different choice mark except that URA3 or TRP1 at multiple copied plasmid described in other example, these marks are present on each wall of YAC.According to example 1 described method the various cotransformation body types of carrying pYAC5 β α and YEpFlagCOLIII 1.6kb are analyzed, analyzed its collagen and produce, the P4H subunit produces and the P4H activity.Then the cotransformation body that contains pYAC5 β α+YEpFlagCOLIII 1.6kb is screened by the method for top embodiment, seek hydroxylation collagen, to determine the 60kDa band in the Western trace, this band is equivalent to the MAbs of anti-α and β and Flag, and more than operation is carried out after inducing.Only after inducing, just identify α and β subunit with semi-lactosi.Only after α that induces P4H and β subunit, just identify hydroxylation albumen.

Example 5: the collagen expression frame is imported pYAC5 and pYAC5 β α.

By digesting the YEpFlag linearizing with ScaI, the single recognition site of described restriction endonuclease on can the ampicillin resistance gene [bla] of cracking β-Nei Xiananmei, on the collagen insertion fragment of 1.6kb, there is not the ScaI site, so ScaI can be used for linearizing with YEpFlagCOLIII 1.6kb.Linear DNA is used to transform the yeast that contains pYAC5 or pYAC5 β α.By MAbs[M1 or M2 with anti-Flag] colony hybridization that carries out identifies the yeast conversion body of the collagen that can produce the Flag mark.Also identified the bacterium colony that has additional copy bla gene [multiple copied].Measure to find to produce the bacterium colony of relatively large β-Nei Xiananmei by PEDAC, the YEpFlagCOLIII 1.6kb with a copy is inserted among the pYAC5 or pYAC5 β α of host strain, is equivalent to the bacterium colony that Mabs M1 or M2 are positive.The beta-lactam enzymic activity that has improved is by due to the gene amplification, and this amplification is owing to producing at linearizing bla gene on the YEpFlagCOLIII 1.6kb and the homologous recombination between the bla gene on the pYAC.The new plasmid that is produced among pYAC5 by inserting YEpFlagCOLIII 1.6kb carrier or the pYAC5 β α is named as pYAC-COLIII 1.6kb and pYAC5 β α-COLIII 1.6kb (Fig. 6).Express experiment, only on YAC[pYAC β α-COLIII 1.6kb, contain all three genes, and induced the bacterial strain of P4H can produce hydroxylation collagen with semi-lactosi.

Example 6: synthetic proteic clone of collagen and expression.

Disclosed the method for a kind of preparation " synthetic/novel " collagen protein, this method is included in the oligonucleotide tumor-necrosis factor glycoproteins (wherein XY=LA, ER, PA or AP) of external establishment encoded peptide GPP.GPP.GXY.Synthetic collagen sequence is carried out the engineering operation, make its tyrosine residues that contains high per-cent, can give the tropocollagen molecule thermostability because this residue has been proved to be.Is specific (being LA, ER, PA or AP) to the locational residue of XY to selecting because from statistics they with bigger measuring the present fibril collagen.

Can link together the mixture of the synthetic oligonucleotide of coding GPP.GPP.GXY, to form the dna fragmentation of different lengths, this dna fragmentation coding has the synthetic collagen protein of differing molecular size and different physical features.Can be with these synthetic gene fragment clonings in various expression vectors, so that in yeast, produce the collagen product subsequently.Show the sketch of the method for the synthetic oligonucleotide that makes up coding collagen at Fig. 7, wherein only showing XY with form illustrated is ER, LA, AP, PA.

Synthesize described synthetic oligonucleotide by described oligonucleotide is linked together, and prepared some libraries (maximum visible DNA length is approximately 1000bp, the polypeptide of about 350 amino-acid residues of encoding) of containing all lengths gene fragment.

Example 7: the synthetic hydroxylation triple helical proteins that is structured in stably express in the yeast

Ability according to its known combination and activated blood platelet is selected one section III Collagen Type VI [the integrin binding site by close-Gly-Leu-Ala-Gly-Ala-Pro-Gly-Leu-Arg carries out].Comprise a fragment that repeats to form by 5 GXY-X-Y in the terminal side of its N-, and comprise that in the terminal side of its C-7 GXY-X-Y repeat, be included in basic repeating unit in the described synthetic fragment with generation.This repeating sequences is GGKGDAGAPGERGPP-GLAGAPGLR-GGAGPPGPEGGKGAAGPPGPP.This is equivalent to the residue 637-681 (Nucleotide 1909-2043) of COL3A1 gene [Met=1] lining.5 ' end at this DNA comprises an EcoRI and NheI site, so that form an initial methionine by the NheI site.Therefore its aminoterminal sequence is MGAPGAP, and wherein, GAPGAP is a native sequences, and this sequence is arranged in the tumor-necrosis factor glycoproteins side of COL3A1.By joint described repetition is repeated to be connected with second kind, introduce a Bsp120I site thus, manipulate after being provided with, and between first and second repeating units, provide GGP sequence.By a joint described second repetition repeated to be connected with the 3rd, introduce a DssHII site [also being] thus and produce aminoacid sequence GAR for later operation.The 3rd multiple side has two extra GPP triplets, a GCC triplet and final GLEGPRG.This is the result who comprises the sequence that XhoI, SacI and NheI site can be provided.Comprise these sites and make that the clone in stage has bigger handiness afterwards.Provide an in-frame terminator codon by the NheI site.

Described synthetic fragment is to be begun with three pieces by the primer of anti-COL3A1 by PCR.Fragment 1 is EcoRI-NheI-Met-[GAP] the 2-[repetition] 1-Bsp120I.The primer that is used for this purpose is 5 '-aattccatgggtgctccaggtgctcc-3 ' [upstream] [primer U101] and 5 '-ggcc-acctggtggacctggtgg-3 '] [downstream] [primer D101].Second PCR fragment is to use primer 5 '-ggcccggtggtaagggtgacgc-3 ' [upstream] [primer 102] and 5 '-cgcgc-acctggtggacctgg-3 '] [downstream] [primer D102].The 3rd is repeated employed primer to being 5 '-cgcgc-ggtggtaagggtgacgctgg-3 ' [upstream] [primer U103] and 5 '-acaaccctggtggacctggtggacctggtggacctgggtgg-3 ' [downstream] [D103].Above three fragments of reacting from PCR are carried out gel-purified, and link together.To take turns the template of PCR as another from the DNA that connects mixture, this PCR uses primer U101 and is positioned at 3 ' terminal new primer [5 '-ctagccccgcggaccctcgagaccacaacaaccctggtgg-3 '] [downstream] [primer D104].Produce a band that is approximately 500bp, and carry out gel-purified,, and, change intestinal bacteria then over to pYX141 (Ingenous catalog number MBV-025-10) [LEU2-CEN-p786] connection that digested with EcoRI-NheI equally with EcoRI-NheI digestion.By PCR screening transformant, be used for second segmental primer, the DNA that comes from positive bacterium colony is prepared on a small quantity, and, seek about 500bp and insert segmental existence by screening with EcoRI-NheI digestion.This storage plasmid is named as pYX-SYN-C3-1.Change this EcoRI-NheI fragment over to pYX243[2u-LEU2-pGAL] in (Ingenous catalog number MBV-035-10), to produce pYX-SYN-C3-2, and this plasmid imported in yeast host cell, this cell comprises the P4H α that coding carries and the nucleotide sequence [pYEUra3.3.12 β #39 α #5 or pYAC α β] of β subunit.Inducing later expression with semi-lactosi is by using MAb 2G8/B1 (Werkmeister﹠amp; Ramshaw, 1991) measure, employed antibody capable recognition sequence GLAGAPGLR.Also the EcoRI-SacII fragment that comes from pYX-SYN-C3-2 will be imported the EcoRI-SacII fragment of YEpFlag, to produce YEpFlag-SYN-C3, this plasmid also is imported into yeast host cell, and this cell can be expressed P4H when inducing with semi-lactosi.In the yeast of inducing, detect the product [the expection size of SYN-C3] that is approximately 18kDa with semi-lactosi by the Western engram analysis.

The nucleotide sequence of SYN-C3 is provided in Fig. 8, the aminoacid sequence of its coded product also is provided simultaneously.

Example 8: use the yeast except that yeast saccharomyces cerevisiae.

The GAL1-10 promotor can work in kluyveromyces, and the ADH2 promotor can be expressed with composition form in schizosaccharomyces pombe.By described expression cassette is transferred in the suitable carrier, other yeast host also can use.For example, confirmed under some occasion that Kluyveromyces lactis has the more weak protein cleavage activity to recombinant products.In addition, pichia pastoris phaff can be used to the expression cassette of α β repeatedly is incorporated in its karyomit(e).

In order to express at pichia pastoris phaff, with the EcoRI-NotI site [pPIC-SYN-C3] among the nucleotide sequence insertion pichia pastoris phaff carrier pPIC9 (Invitrogen, catalog number K1710-01) of the synthetic triple helical proteins [SYN-C3] of the coding disclosed in the embodiment in front.Digest this plasmid with BglII or SalI, then it is imported pichia pastoris phaff, here it is incorporated into respectively AOX1 or the HIS4 site corresponding to BglII or SalI.The nucleotide sequence of coding P4H α and β subunit is also imported pichia pastoris phaff, for the β subunit, use pHIL-D2 (Invitrogen, catalog number K1710-01) EcoRI site, and be incorporated into the HIS4 site, for the α subunit, use pHIL-S1 Invitrogen, catalog number K1710-01) MH1 site is incorporated into HIS4 subsequently.All three expression cassettes all are the control that is subjected to the AOX1 promotor, and by methanol induction.

Example 9: the yeast that has different background by utilization strengthens the expression of prolyl-4-hydroxylase α and β subunit by the GAL1-10 promotor, expresses so that control the semi-lactosi inductive.

α and the β subunit of plasmid pYEUra3.2.12 β #39 α #5[coding P4H can be subjected to the control of GAL1-10 bidirectional promoter] import and have following genotypic yeast host cell: a or α, ura3trp1 egd1 btt1.In these cells, the shortage of EGD1 and BTT1 gene product has caused the high-level semi-lactosi abduction delivering (Hu﹠amp that is started by the GAL4 self promotor such as GAL2, GAL4, GAL7, GAL1-10, MEL1; Ronne, 1994).

The another kind of mechanism that is used to strengthen expression is to use the yeast host cell (Johnston﹠amp that carries the positive transcriptional activator of multiple copied GAL4; Hopper, 1982), by inducing of itself control semi-lactosi.This can cause enhanced to be expressed, because there is not the restriction of the transcriptional activator aspect that is used for the GAL1-10 promotor.Similarly, described yeast host cell can contain the SGE1 gene (Amakasu etc. 1993) of multiple copied, and this also can cause being transcribed by the enhancing that the semi-lactosi evoked promoter carries out.

Also can use the various combinations of described background, i.e. egd1 btt1 SGE1 ^McOr egd1 btt1GAL4 ^McOr egd1 btt1 SG1 ^McGAL4 ^Mc[wherein mc represents multiple copied].

Example 10: with the promoter expression collagen except that ADH2.

Can Nh1I or the collagen coding nucleotide sequence of HindIII-XbaI or the segmental form excision of NruI YEpFlagCOL1.6kb, be inserted in other fusion vector, make it be subjected to the control of other promotor.In addition, for example can NaeI or form excision pADH2 signal-A-of SacI-BglII or XdaI or SpeI or SnaBI or NotI before fragment-Flag collagen expression frame, and it is imported in suitable carrier, as YEplac181 (Gietz﹠amp; Sugino, 1988) or pMH158 (Heuterspreute, 1985), have in the carrier of CEN sequence so that express or import with different copy numbers and host's background.In addition, CEN sequence itself can import the YEpFlag carrier.Can also described expression cassette be excised with the form that does not have the ADH2 promotor with NruI, and import the suitable promotor back of suitable carrier.

As the surrogate of ADH2 promotor, can use the CUP1 promotor in such as the carrier of pYELC5, to express collagen coding nucleotide sequence (Macreadie etc., 1989).This promotor is by interpolation copper (being copper sulfate) inductive, and has enhancing induced environment and the active advantage of enhancing P4H during coexpression.Operable second promotor is the TIP1 promotor, and this promotor is by cold shock inducible.Here, need not to carry out hydroxylation and can improve the stability of expressing collagen, its way is to come abduction delivering by the yeast of growth is transferred to 18 ℃ from 30 ℃.

The inventive method provides the mode with yeast host cell stably express triple helical proteins.Product of the present invention can be natural and synthetic collagen, natural and synthetic collagen fragment and natural and synthetical glue former state albumen.Synthetic product may have enhanced or new function (for example, containing a RGD and/or a YIGSR sequence that comes from silk company's albumen (fibrorectin) and ln).Described product can be used for multiple purpose, comprise biograft production, soft sclerous tissues increases, wound/burn bandage, be used for the sphincter muscle increase that the urinary incontinence and stomach reflux, periodontal disease, blood vessel graft, delivery system is used for the cell delivery system of the natural factor and the conduit of neurotization.

Reference:

Ala-Kokko etc. (1989) journal of biological chemistry 260,509-516

Amakasu, H. etc. (1993) genetics 134,675-683

D ' Alessio, M. etc. (1988) gene 67,105-115

De Wet, the biological and The Chemicals 262 of W etc. (1987), 16032-16036

Cheah, K.S.E. etc. (1985) Proc.Natl.Acad.Sci.USA 82,2556-2559

Nature such as Cohen D (1993) 366,698-701

Gietz, R.D.﹠amp; Sugino, A. (1988) gene 74,527-534

Glattauer, V. etc. (1997) journal of biological chemistry 323,45-49

Goff, G. etc. (1984) gene 25,179-188

Helaakoski, T. etc. (1989) Proc.Natl.Acad.Sci.USA 86,4392-4396

Hueterspreute, M. etc. (1985) gene 34,363-366

Hitzeman, R.A. etc. (1981) nature 293,717-722

Hu, G.Z.﹠amp; Ronne, H. (1994) nucleic acids research 22,2740-2743

Johnston，S.A.&Hopper，J.E.(1982)Proc.Natl.Acad.Sci.USA?79，6971-6975

Kuhn RM﹠amp; Ludwig RA (1994) gene 141,125-127

(1996) nucleic acids research 24 No.21 such as Larin Z, 4192-4196

Macreadie, I.G. etc. (1989) plasmid 21,147-150

Macreadie, (1994) biotechnology such as I.G. and applied biochemistry 19,265-269

Mahadevan, S.﹠amp; Struhl, K. (1990) molecular cytobiology 10,4447-4455

Miller, E.J.﹠amp; Rhodes, R.K. (1982) Enzymology method 82,33-64

Pihlajaniemi, T waits (1987) EMBO J 6,643-649

St.John, T.P.﹠amp; Davis R.W. (1981) molecular biology magazine 152,285-316

Thukral, S.K. etc. (1991) molecular cytobiology 11,699-704

Trelstad, R.L. (1982) natural collagen separates.See the immunochemistry first roll of extracellular matrix (H.Furthmayr work) CRC press, 31-41

Tuite, M.F. etc. (1982) EMBO J.1,603-608

Westerhausen, A etc. (1991) matrix 11,375-379

Werkmeister, J.A.﹠amp; Ramshaw, J.A.M. (1991) journal of biological chemistry, 274,895-898

Wiseman, A. (1991) comes from zymic genetic engineering albumen and enzyme: production control.EllisHorwood，New?York

Those skilled in the art of the present invention are appreciated that can be at the design that does not exceed broad sense of the present invention and model Under the prerequisite of enclosing to carrying out multiple change with the present invention shown in the particular form and/or changing Advance. Therefore, say that from all angles embodiment of the present invention should be illustrated as illustrative rather than limit Qualitatively.

Claims

1. method of in yeast, producing the hydroxylation triple helical proteins, this method may further comprise the steps:

2. method as claimed in claim 1, wherein, described product coding nucleotide sequence is the nucleotide sequence of coding natural collagen or its sheet.

3. method as claimed in claim 2, wherein, described product coding nucleotide sequence is to be selected from COL1A1, COL1A2, COL2A1 and COL3A1 and fragment.

4. method as claimed in claim 3, wherein, described product coding nucleotide sequence is COL3A1.

5. method as claimed in claim 1, wherein, described product coding nucleotide sequence is that coding has the synthetic polypeptide of following general formula or the nucleotide sequence of peptide: (A) _l-(B) _m-(Gly-X-Y) _n-(C) _o-(D) _pWherein, Gly is a glycine, X and Y represent identical or different amino acid, X and Y can be different between Gly-X-Y triplet and the Gly-X-Y triplet, and but, Y wherein is necessary 〉=1 proline(Pro), A and D are polypeptide or peptide domain, and it can comprise or not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, B and C are intervening sequences, it does not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, n are 2-1500, and l, m, o and p are selected from 0 or 1 independently of one another.

6. the method according to any one of the preceding claims, wherein, described first and second nucleotide sequences are reached by the two-way startup subsequence table.

7. method as claimed in claim 6, wherein, described two-way startup subsequence is a yeast GAL1-10 promoter sequence.

8. the method according to any one of the preceding claims, wherein, described first and second nucleotide sequences are to come from bird or mammals.

9. method as claimed in claim 8, wherein, described first and second nucleotide sequences are to come from the mankind.

10. the method according to any one of the preceding claims, wherein, described second and product coding nucleotide sequence coding secretion signal, making expressed P4H and product polypeptide or peptide is secretion property.

11. the method according to any one of the preceding claims wherein, imports yeast host cell with described first, second with the product coding nucleotide sequence, and it is appeared on one or several carrier that contains the CEN sequence.

12. the method according to any one of the preceding claims, wherein, described first, second and product coding nucleotide sequence are imported yeast host cell, make it appear on one or more carriers that contain the CEN sequence and on one or both high copy number carriers.

13. as the method for claim 11 or 12, wherein, the described carrier that one or more contain the CEN sequence is selected from yac vector.

14. as the method for claim 12 or 13, wherein, described one or both high copy number carriers are selected from the YEp plasmid.

15. as the method for claim 11, wherein, described first, second is present on the single Y AC carrier with the product coding nucleotide sequence.

16. the method according to any one of the preceding claims, wherein, described yeast host cell is selected from genus kluyveromyces, yeast belong, Schizosaccharomyces, Yarrowia and Pichia.

17. yeast host cell that can produce the hydroxylation triple helical proteins, described yeast host cell comprises first nucleotide sequence of a coding P4H α subunit, second nucleotide sequence and one or several product coding nucleotide sequence of a coding P4H β subunit, described product coding nucleotide sequence encode one or more polypeptide or peptide, these polypeptide or peptide generate later on described hydroxylation triple helical proteins at hydroxylation, and each of described first, second and product coding nucleotide sequence all operationally is connected with promoter sequence; Wherein, described first, second and product coding nucleotide sequence and the promoter sequence that is operably connected accordingly thereof are carried on one or several reproducible dna molecular, and this molecule is stably kept by described yeast host cell and separates.

18. as the yeast host cell of claim 17, wherein, described product coding nucleotide sequence is the nucleotide sequence of coding natural collagen or its sheet.

19. as the yeast host cell of claim 18, wherein, described product coding nucleotide sequence is to be selected from COL1A1, COL1A2, COL2A1 and COL3A1 and fragment.

20. as the yeast host cell of claim 19, wherein, described product coding nucleotide sequence is COL3A1.

21. as the yeast host cell of claim 17, wherein, described product coding nucleotide sequence is that coding has the synthetic polypeptide of following general formula or the nucleotide sequence of peptide: (A) _l-(B) _m-(Gly-X-Y) _n-(C) _o-(D) _pWherein, Gly is a glycine, X and Y represent identical or different amino acid, X and Y can be different between Gly-X-Y triplet and the Gly-X-Y triplet, and but, Y wherein is necessary 〉=1 proline(Pro), A and D are polypeptide or peptide domain, and it can comprise or not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, B and C are intervening sequences, it does not comprise (Gly-X-Y) that triple helix forms _nTumor-necrosis factor glycoproteins, n are 2-1500, and l, m, o and p are selected from 0 or 1 independently of one another.

22. as each described yeast host cell among the claim 17-21, wherein, described first and second nucleotide sequences are reached by the two-way startup subsequence table.

23. as the yeast host cell of claim 22, wherein, described two-way startup subsequence is a yeast GAL1-10 promoter sequence.

24. as each described yeast host cell among the claim 17-23, wherein, described first and second nucleotide sequences are to come from bird or mammals.

25. as the yeast host cell of claim 24, wherein, described first and second nucleotide sequences are to come from the mankind.

26. as each described yeast host cell among the claim 17-25, wherein, described second and product coding nucleotide sequence coding secretion signal, making expressed P4H and product polypeptide or peptide is secretion property.

27. as each described yeast host cell among the claim 17-26, wherein, described first, second imported yeast host cell with the product coding nucleotide sequence, it appeared on one or several carrier that contains the CEN sequence.

28. as each described yeast host cell among the claim 17-26, wherein, described first, second and product coding nucleotide sequence are imported yeast host cell, make it appear on one or more carriers that contain the CEN sequence and on one or both high copy number carriers.

29. as the yeast host cell of claim 27 or 28, wherein, the described carrier that one or more contain the CEN sequence is selected from yac vector.

30. as the yeast host cell of claim 28 or 29, wherein, described one or both high copy number carriers are selected from the YEp plasmid.

31. as the yeast host cell of claim 27, wherein, described first, second is present on the single Y AC carrier with the product coding nucleotide sequence.

32. as each described yeast host cell among the claim 17-31, wherein, described yeast host cell is selected from genus kluyveromyces, yeast belong, Schizosaccharomyces, Yarrowia and Pichia.

33. triple helical proteins of producing by each described method among the claim 1-16.

A 34. biomaterial or treatment product that contains the triple helical proteins of producing by each described method among the claim 1-16.